期刊文献+

登革病毒1型E蛋白的原核细胞表达及多克隆抗体的制备 被引量:1

Prokaryotic expression of E protein of dengue virus type 1 and preparation of polyclonal antibody
下载PDF
导出
摘要 目的构建登革病毒1型(DENV-1)E蛋白的原核细胞表达载体并进行原核细胞表达,并制备其多克隆抗体。方法利用聚合酶链反应(PCR)扩增DENV-1E蛋白序列,经酶切后将其插入原核细胞表达载体pET-32a(+),构建重组质粒pET-32-D1-E。重组质粒转化E.Coli Rosetta(DE3)感受态细胞,目的蛋白经异丙基-D-硫代半乳糖苷(IPTG)诱导表达,纯化后采用十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)初步分析蛋白表达情况,并用纯化后的表达蛋白免疫家兔,制备该蛋白的多克隆抗血清,用间接酶联免疫吸附测定(ELISA)检测抗体的效价,Western blot检测抗体的特异性。结果成功构建了pET-32-D1-E原核细胞表达重组质粒,DENV-1E蛋白获得高效表达;纯化后的重组蛋白免疫家兔获得的特异性抗血清效价为1∶25 600,Western blot证实其特异性良好。结论成功构建了DENV-1E蛋白的原核细胞表达载体,并制备了可用于DENV快速检测的高效多克隆抗体。 Objective To construct prokaryotic expression vector for E protein of dengue virus type 1 (DENV-1) and induce its expression and prepare its polyclonal antibody.Methods Polymerase chain reaction (PCR) was used to amplify DENV-1Eprotein sequences which were inserted into prokaryotic expression vector pET-32a (+) after restriction enzyme digestion.Recombinant plasmid pET-32-D1-E was constructed and were transformed into E.Coli Rosetta (DE3) competent cells.The target protein was in- duced to expression by isopropyl-beta-D-thiogalactopyranoside (IPTG)and preliminarily analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) after purification.The purified expression protein was adopted to immunize rabbits in order to prepare its polyclonal antibody.Enzyme-linked immunosorbent assay (ELISA) was employed to detect the antibody titer and Western blot to test its specificity.Results Recombinant plasmid pET-32-D1-E plasmid expression in prokaryocyte was suc- cessfully constructed and DENV-1 Eprotein was highly expressed.The titer of the polyclonal antibody obtained by immunization was 1∶25 600 and its high specificity was confirmed by Western blot.Conclusion Prokaryotic expression vector of DENV-1 E protein has been successfully constructed and efficient polyclonal antibody for rapid DENV detection has been prepared.
出处 《国际检验医学杂志》 CAS 2013年第23期3107-3109,共3页 International Journal of Laboratory Medicine
基金 国家高技术研究发展计划(SS2012AA020901)
关键词 登革病毒 原核细胞 抗体 多克隆 遗传载体 dengue virus prokaryotic cells antibodies polyclonal genetic vectors
  • 相关文献

参考文献11

  • 1Monath TP. Dengue:the risk to developed and developing countries[J].{H}Proceedings of the National Academy of Sciences(USA),1994,(07):2395-2400.
  • 2Kroeger A,Nathan M,Hombach J. Dengue[J].Nat Rev Micro-biol,2004,(05):360-361.
  • 3Jaiswal S,Khanna N,Swaminathan S. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain Ⅲ protein in Escherichia coli[J].{H}Protein Expression and Purification,2004,(01):80-91.
  • 4Rey FA. Dengue virus envelope glycoprotein structure:new insight into its interactions during viral entry[J].{H}Proceedings of the National Academy of Sciences(USA),2003,(12):6899-6901.
  • 5Modis Y,Ogata S,Clements D. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein[J].{H}Journal of Virology,2005,(02):1223-1231.doi:10.1128/JVI.79.2.1223-1231.2005.
  • 6Modis Y,Ogata S,Clements D. A ligand-binding pocket in the dengue virus envelope glycoprotein[J].{H}Proceedings of the National Academy of Sciences(USA),2003,(12):6986-6991.
  • 7Crill WD,Roehrig JT. Monoclonal antibodies that bind to domain Ⅲ of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells[J].{H}Journal of Virology,2001,(16):7769-7773.
  • 8Hermida L,Bernardo L,Martín J. A recombinant fusion protein containing the domain Ⅲ of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates[J].{H}VACCINE,2006,(16):3165-3171.
  • 9Chen Y,Maguire T,Hileman RE. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate[J].{H}Nature Medicine,1997,(08):866-871.
  • 10Pattnaik P,Babu JP,Verma SK. Bacterially expressed and refolded envelope protein (domain Ⅲ) of dengue virus type-4 binds heparan sulfate[J].{H}Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences,2007,(1/2):184-194.

同被引文献13

  • 1Guzman MG, Kouri G. Dengue: an update [ J ]. Lancet Infect Dis, 2002, 2 ( 1 ) : 33-42.
  • 2Sinha G. Sanofi's dengue vaccine first to complete phase 3 [J]. Nat Biotechnol, 2014, 32(7) : 605-606.
  • 3Leitmeyer KC, Vaughn DW, Watts DM, et al. Dengue virus structural differences that correlate with pathogenesis[J]. J Virol, 1999, 73(6) : 4738-4747.
  • 4Li XQ, Qiu LW, Chert Y, et al. Dengue virus envelope domain Ⅲ immunization elicits predominantly cross-reactive, poorly neu-tralizing antibodies localized to the AB loop: implications for den- gue vaccine design[J]. J Gen Virol, 2013, 94(Pt 10): 2191- 2201.
  • 5Nowak T, Wengler G. Analysis of disulfides present in the mem- brane proteins of the West Nile flavivirus [ J ]. Virology, 1987, 156(1) : 127-137.
  • 6Wengler G, Wengler G. Cell-associated West Nile flavivirus is covered with E +pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release[J]. J Virol, 1989, 63(6) : 2521-2526.
  • 7韦永龙,李轶女,张志芳,沈桂芳.杆状病毒表达系统及其应用进展[J].生物技术通报,2010,26(10):1-7. 被引量:16
  • 8郭勇晖.登革病毒重组包膜蛋白表达及其应用的研究进展[J].广东医学,2012,33(9):1350-1352. 被引量:2
  • 9李竹石,林华,杨健,杨会强,曾献武,赵宇,刘俐,刘莉娜,康庄,俞永新,李玉华.登革病毒4型E蛋白的表达与多克隆抗体的制备[J].基础医学与临床,2012,32(11):1337-1341. 被引量:1
  • 10林华,杨会强,李竹石,杨健,赵宇,刘俐,葛永红,曾献武,曹毅,乔代蓉,李玉华.登革病毒3型E蛋白的原核表达及抗体的制备[J].中华微生物学和免疫学杂志,2013,33(5):371-374. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部